Alessandra Tedeschi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Atrial Fibrillation

Hepatitis C Virus

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

Hematological oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesca Romana Mauro, Giovanni Barosi, Pier Luigi Luigi Zinzani
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel. Hematological oncology 42 (2) (2024)
Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John Francis Seymour
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pier Luigi Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesco Zaja, Giovanni Barosi
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel. Hematological oncology (2023)
John N Allan, Ian W Flinn, Tanya Siddiqi, Paolo Ghia, Constantine S Tam, Thomas J Kipps, Paul M Barr, Anna Elinder Camburn, Alessandra Tedeschi, Xavier C Badoux, Ryan Jacobs, Bryone J Kuss, Livio Trentin, Cathy Zhou, Anita Szoke, Christopher Abbazio, William G Wierda
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci, Riccardo Moia, Clara Deambrogi, Silvia Rasi, Francesco Autore, Michele Merli, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo', Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta, Valeria Spina, Alessio Bruscaggin, Katia Pini, Deborah Piffaretti, Maria Cristina Pirosa, Matin Salehi, Joyce Marques de Almeida, Jakob Passweg, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Georg Stussi, Valter Gattei, Paolo Ghia, Michael Gregor, Francesco Passamonti, Luca Laurenti, Gianluca Gaidano, Alessandra Tedeschi, Davide Rossi, Adalgisa Condoluci
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia. Hematological oncology (2022)
Pier Luigi Luigi Zinzani, Maurizio Martelli, Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Paolo Sportoletti, Alessandra Tedeschi, Marzia Varettoni, Chiara Rusconi
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement. Hematological oncology 40 (4) (2022)
Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Maurizio Martelli, Paolo Sportoletti, Chiara Rusconi, Pier Luigi Luigi Zinzani, Alessandra Tedeschi, Marzia Varettoni
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement. Hematological oncology 40 (3) (2022)
Adalgisa Condoluci, Lisa Milan, Gabriela Forestieri, Lodovico Terzi di Bergamo, Valeria Spina, Alessio Bruscaggin, Clara Deambrogi, Riccardo Moia, Marina Deodato, Gaby Fahrni, Roberta Mattarucchi, Michele Merli, Bernhard Gerber, Georg Stussi, Francesco Passamonti, Michael Gregor, Alessandra Tedeschi, Gianluca Gaidano, Davide Rossi, Luca Ceriani
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib. Hematological oncology (2022)
Riccardo Moia, Riccardo Dondolin, Maria Stefania De Propris, Donatella Talotta, Samir Mouhssine, Francesca Perutelli, Gianluigi Reda, Veronica Mattiello, Gian Matteo Rigolin, Marina Motta, Jacopo Olivieri, Renato Fanin, Omar Perbellini, Isacco Ferrarini, Francesca Romana Mauro, Ilaria Del Giudice, Luca Laurenti, Annamaria Tomasso, Massimo Gentile, Anna Maria Frustaci, Alessandra Tedeschi, Alessandro Gozzetti, Caterina Stelitano, Chiara Rusconi, Carol Moreno, Francesco Forconi, Roberto Marasca, Marta Coscia, Davide Rossi, Robin Foà, Gianluca Gaidano
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. Hematological oncology (2022)
Sara Rattotti, Virginia Valeria Ferretti, Chiara Rusconi, Andrea Rossi, Stefano Fogazzi, Luca Baldini, Pietro Pioltelli, Monica Balzarotti, Lucia Farina, Andrés J M Ferreri, Daniele Laszlo, Valentina Speziale, Marzia Varettoni, Roberta Sciarra, Lucia Morello, Alessandra Tedeschi, Marco Frigeni, Irene Defrancesco, Caterina Zerbi, Elena Flospergher, Maria Elena Nizzoli, Enrica Morra, Luca Arcaini, null null
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network. Hematological oncology 37 (2) (2019)
Anna Maria Frustaci, Michele Nichelatti, Marina Deodato, Giulia Zamprogna, Periana Minga, Maria Luisa Pioltelli, Roberto Cairoli, Alessandra Tedeschi
Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience. Hematological oncology 38 (1) (2019)
Andrea Visentin, Marina Deodato, Francesca R Mauro, Francesco Autore, Gianluigi Reda, Candida Vitale, Stefano Molica, Gian Matteo Rigolin, Francesco Piazza, Laura Cesini, Alessandra Tedeschi, Luca Laurenti, Ramona Cassin, Marta Coscia, Antonio Cuneo, Robin Foà, Gianpietro Semenzato, Livio Trentin
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia. Hematological oncology 37 (4) (2019)
Jorge J Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby Andrew Eyre, Julio C Chavez, Kenneth H Shain, Samar Issa, Maria Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S Tam, Alessandra Tedeschi, Stephen M Ansell, Lakshmi Nayak, Steven P Treon
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study. Blood 133 (4) (2018)
Alessandra Tedeschi, Concetta Conticello, Rita Rizzi, Giulia Benevolo, Luca Laurenti, Maria Teresa Petrucci, Francesco Zaja, Marzia Varettoni
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia. Hematological oncology 37 (2) (2018)